Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Overcoming fragmentation of health research in Europe: lessons from COVID-19.
Sipido KR, Antoñanzas F, Celis J, Degos L, Frackowiak R, Fuster V, Ganten D, Gay S, Hofstraat H, Holgate ST, Krestin G, Manns M, Meunier F, Oertel W, Palkonen S, Pavalkis D, Rübsamen-Schaeff H, Smith U, Stallknecht BM, Zima T. Sipido KR, et al. Among authors: rubsamen schaeff h. Lancet. 2020 Jun 27;395(10242):1970-1971. doi: 10.1016/S0140-6736(20)31411-2. Epub 2020 Jun 16. Lancet. 2020. PMID: 32559417 No abstract available.
Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study.
Stoelben S, Arns W, Renders L, Hummel J, Mühlfeld A, Stangl M, Fischereder M, Gwinner W, Suwelack B, Witzke O, Dürr M, Beelen DW, Michel D, Lischka P, Zimmermann H, Rübsamen-Schaeff H, Budde K. Stoelben S, et al. Transpl Int. 2014 Jan;27(1):77-86. doi: 10.1111/tri.12225. Transpl Int. 2014. PMID: 24164420 Free article. Clinical Trial.
Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation.
Chemaly RF, Ullmann AJ, Stoelben S, Richard MP, Bornhäuser M, Groth C, Einsele H, Silverman M, Mullane KM, Brown J, Nowak H, Kölling K, Stobernack HP, Lischka P, Zimmermann H, Rübsamen-Schaeff H, Champlin RE, Ehninger G; AIC246 Study Team. Chemaly RF, et al. N Engl J Med. 2014 May 8;370(19):1781-9. doi: 10.1056/NEJMoa1309533. N Engl J Med. 2014. PMID: 24806159 Free article. Clinical Trial.
Pharmacokinetics and safety of letermovir, a novel anti-human cytomegalovirus drug, in patients with renal impairment.
Kropeit D, Scheuenpflug J, Erb-Zohar K, Halabi A, Stobernack HP, Hulskotte EGJ, van Schanke A, Zimmermann H, Rübsamen-Schaeff H. Kropeit D, et al. Among authors: rubsamen schaeff h. Br J Clin Pharmacol. 2017 Sep;83(9):1944-1953. doi: 10.1111/bcp.13292. Epub 2017 May 5. Br J Clin Pharmacol. 2017. PMID: 28345163 Free PMC article. Clinical Trial.
Intravenous Hydroxypropyl β-Cyclodextrin Formulation of Letermovir: A Phase I, Randomized, Single-Ascending, and Multiple-Dose Trial.
Erb-Zohar K, Kropeit D, Scheuenpflug J, Stobernack HP, Hulskotte E, van Schanke A, Zimmermann H, Rübsamen-Schaeff H. Erb-Zohar K, et al. Among authors: rubsamen schaeff h. Clin Transl Sci. 2017 Nov;10(6):487-495. doi: 10.1111/cts.12483. Epub 2017 Jul 4. Clin Transl Sci. 2017. PMID: 28675594 Free PMC article. Clinical Trial.
14 results